Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell CarcinomaHui Luo, Guangqiang Zhao, Jin Lü et al.|JAMA|2021Cited by 821
Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trialsAlexa B. Kimball, Elisa Muscianisi, Alice B. Gottlieb et al.|The Lancet|2023Cited by 318